Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enzyme-based nanomedicine for tumor microenvironment modulation in cancer therapy.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

ISX-TWIST1 reprograms CD47-inflammasome signaling to reshape the immune microenvironment in liver cancer.

Experimental hematology & oncology·2026
Same author

Stimuli-Responsive Nanozyme Reprograms Tumor Immunometabolism and Overcomes Therapeutic Resistance in Hepatocellular Carcinoma.

ACS nano·2026
Same author

Spike protein-induced VSIR-ISX signaling disrupts metabolic homeostasis and promotes COVID-19-related immune dysfunction.

Cell biology and toxicology·2025
Same author

Delayed open-heart operation to remove migrated intracardiac inferior vena cava stents in a living donor liver transplantation recipient: a case report.

Nagoya journal of medical science·2025
Same author

Routine single-incision laparoscopic common bile duct exploration with concomitant cholecystectomy for elderly patients: a 6-year retrospective comparative study.

Surgical endoscopy·2024

Related Experiment Video

Updated: Jun 6, 2026

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software
07:32

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software

Published on: April 12, 2024

Leptin in hepatocellular carcinoma.

Shen-Nien Wang1, King-Teh Lee, Chen-Guo Ker

  • 1Division of Hepatobiliary Surgery, Department of Surgery, Kaohsiung Medical University Hospital, 100 Tzyou 1st Road, San-Ming District, Kaohsiung 807, Taiwan, China. snwang@kmu.edu.tw

World Journal of Gastroenterology
|December 15, 2010
PubMed
Summary

Leptin, a hormone from fat tissue, may play a role in hepatocellular carcinoma (HCC) development, particularly in cases without clear risk factors. Understanding leptin

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Related Experiment Videos

Last Updated: Jun 6, 2026

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software
07:32

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software

Published on: April 12, 2024

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Area of Science:

  • Hepatology
  • Endocrinology
  • Oncology

Background:

  • Established hepatocellular carcinoma (HCC) risk factors include viral hepatitis, alcohol, and aflatoxins.
  • A significant portion of HCC cases lack identifiable risk factors, with nonalcoholic fatty liver disease (NAFLD) implicated in 'cryptogenic' HCC.
  • Adipose tissue functions as an endocrine organ, secreting adipokines like leptin, which is linked to metabolic syndrome and obesity.

Purpose of the Study:

  • To review the potential mechanisms by which leptin contributes to the development of hepatocellular carcinoma (HCC).
  • To explore leptin's role in liver fibrogenesis and carcinogenesis.
  • To identify leptin as a potential therapeutic target for HCC.

Main Methods:

  • Literature review of studies investigating leptin's role in liver physiology and cancer.
  • Analysis of in vitro data on leptin's fibrogenic effects.
  • Examination of evidence linking leptin dysregulation to metabolic disorders and cancer.

Main Results:

  • Leptin, produced by adipose tissue, is involved in energy homeostasis and has demonstrated fibrogenic roles in the liver.
  • Altered leptin and leptin receptor expression is associated with metabolic disorders and various human cancers.
  • Emerging evidence suggests leptin directly influences HCC carcinogenesis and progression.

Conclusions:

  • Leptin's multifaceted roles in energy balance, liver fibrogenesis, and carcinogenesis suggest its involvement in HCC development.
  • Further research into leptin's mechanisms in HCC is warranted.
  • Leptin may represent a novel therapeutic target for hepatocellular carcinoma.